Organogenesis Holdings (ORGO) Return on Capital Employed Growth (1y) (2018 - 2026)
Organogenesis Holdings (ORGO) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -309.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -309.00 |
| Mar 31, 2026 | 632.00 |
| Dec 31, 2025 | 1,017.00 |
| Sep 30, 2025 | 136.00 |
| Jun 30, 2025 | -274.00 |
| Mar 31, 2025 | -916.00 |
| Dec 31, 2024 | -361.00 |
| Sep 30, 2024 | -948.00 |
| Jun 30, 2024 | -734.00 |
| Mar 31, 2024 | -159.00 |
| Dec 31, 2023 | -261.00 |
| Sep 30, 2023 | -307.00 |
| Jun 30, 2023 | -902.00 |
| Mar 31, 2023 | -1,150.00 |
| Dec 31, 2022 | -1,638.00 |
| Sep 30, 2022 | -1,719.00 |
| Jun 30, 2022 | -1,852.00 |
| Mar 31, 2022 | -727.00 |
| Dec 31, 2021 | 876.00 |
| Sep 30, 2021 | 2,426.00 |